Українська English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)
DOI: https://doi.org/10.15407/fz

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2022; 68(5): 79-88

INFLUENCE OF SEROTONIN ON THE METABOLISM OF BONE TISSUE

I.G. Litovka

    Bogomolets Institute of Physiology of the National Academy of Sciences of Ukraine, Ukraine
DOI: https://doi.org/10.15407/fz68.05.079


Abstract

This literature review presents data on the influence of serotonin on the metabolism of bone tissue. The mechanisms by which serotonin affects the formation and resorption of bone, depending on the site of synthesis (central or peripheral), as well as the cells and receptor subtypes that are activated, have been considered. A number of issues for further research are highlighted, in particular, the dose-response relationship and side effects during chronic and long-term treatment with various selective serotonin reuptake inhibitors.

Keywords: serotonin; metabolism; bone tissue

Full text: (PDF, in Ukrainian)

References

  1. Zhernoklov U, Berezovskyi V, Litovka I. Influence of exoand endogenous factors on bone remodelling in Wistar rats. Eur J Techn Natl Sci. 2016;4:3-8. CrossRef
  2. Litovka I.G. The role of metabolic changes in the development of osteopenic syndrome. Physiol J. 2021; 67(2):67-75. CrossRef
  3. Dimitri P, Rosen C. The central nervous system and bone metabolism: an evolving story. Calcified Tissue International. 2017;100(5):476-85. CrossRef PubMed
  4. Brinton DL, Simpson AN, Fominaya CE, LaRue AC. Impact of selective serotonin reuptake inhibitors in the veteran population: 10-year risk outcomes. J Comp Eff Res. 2019;8:431-40. CrossRef PubMed
  5. Watts NB. Adverse bone effects of medications used to treat non-skeletal disorders. Osteoporos Int. 2017;28:2741-6. CrossRef PubMed
  6. Weaver SR, Fricke HP, Xie C, Lipinski RJ, Vezina CM, Charles JF, et al. Peripartum fluoxetine reduces maternal trabecular bone after weaning and elevates mammary gland serotonin and PTHrP. Endocrinology. 2018;159:2850-62. CrossRef PubMed PubMedCentral
  7. Lavoie B, Lian JB, Mawe GM. Regulation of bone metabolism by serotonin. Adv Exp Med Biol.2017; 1033:35-46. CrossRef PubMed
  8. Richter T, Paluch Z, Alusik S. The non-antidepressant effects of citalopram: a clinician's perspective. Neuro Endocrinol Lett. 2014;35(1):7-12.
  9. Feuer AJ, Demmer RT, Thai A, Vogiatzi MG. Use of selective serotonin reuptake inhibitors and bone mass in adolescents: an NHANES study. Bone.2015;78:28-33. CrossRef PubMed
  10. Rauma PH, Honkanen RJ, Williams LJ, Tuppurainen MT, Kroger HP, Koivumaa-Honkanen H. Effects of antidepressants on postmenopausal bone loss-a 5-year longitudinal study from the OSTPRE cohort. Bone. 2016;89:25-31. CrossRef PubMed
  11. Erspamer V. Experimental research on the biological significance of enterochromaffin cells. Arch Physiol. 1937:156-9.
  12. Rapport MM, Green AA, Page IH. Serum vasoconstrictor, serotonin; isolation and characterization. J Biol Chem. 1948;176(3):1243-51. CrossRef
  13. Page IH, Rapport MM, Green AA. The crystallization of serotonin. J Lab Clin Med. 1948;33(12):1606.
  14. Erspamer V, Asero B. Identification of enteramine, the specific hormone of the enterochromaffin cell system, as 5-hydroxytryptamine. Nature. 1952;169(4306):800-1. CrossRef PubMed
  15. Twarog BM, Page IH. Serotonin content of some mammalian tissues and urine and a method for its determination. Am J Phys. 1953; 175(1):157-61. CrossRef PubMed
  16. Fouquet G, Coman T, Hermine O, Cote F. Serotonin, hematopoiesis and stem cells. Pharmacol Res. 2019; 140:67-74. CrossRef PubMed
  17. Cote F, Thevenot E, Fligny C, Fromes Y, Darmon M, Ripoche MA l. Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function. Proc Natl Acad Sci USA. 2003;100:13525-30. CrossRef PubMed PubMedCentral
  18. Walther DJ, Peter JU, Bashammakh S, Hortnagl H, Voits M, Fink H. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science. 2003;299:76. CrossRef PubMed
  19. Bliziotes M, Eshleman A, Burt-Pichat B, et al. Serotonin transporter and receptor expression in osteocytic MLOY4 cells. Bone. 2006;39(6):1313-21. CrossRef PubMed PubMedCentral
  20. Westbroek I, van der Plas A, de Rooij K, Klein-Nulend J, Nijweide PJ. Expression of serotonin receptors in bone. J Biol Chem. 2001;276(31):28961-8. CrossRef PubMed
  21. Yadav VK, Ryu Je-H, Suda N, Tanaka K, Gingrich Jay A, Schütz G. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell. 2008;135(5):825-37. CrossRef PubMed PubMedCentral
  22. Rosen CJ. Serotonin rising - the bone, brain, bowel connection. Engl J Med. 2009;360(10):957-9. CrossRef PubMed
  23. Rosen CJ. Breaking into bone biology: serotonin's secrets. Nat Med. 2009; 15(2):145-6. CrossRef PubMed
  24. Wadhwa R, Kumar M, Talegaonkar S, Vohora D. Serotonin reuptake inhibitors and bone health: A review of clinical studies and plausible mechanisms. Osteoporos Sarcopenia. 2017;3(2):75-81. CrossRef PubMed PubMedCentral
  25. Hensler JG. Serotonin. In: Brady ST. Basic neurochemistry principles of molecular, cellular, and medical neurobiology. 8th ed. Academic. Waltham, MA. 2012; 300-22. CrossRef
  26. Mawe GM, Hoffman JM. Serotonin signalling in the gut - functions, dysfunctions and therapeutic targets. Nat Rev Gastroenterol Hepatol. 2013;10(8):473-86. CrossRef PubMed PubMedCentral
  27. Banovic M, Bordukalo-Niksic T, Balija M, Cicin-Sain L, Jernej B. Platelet serotonin transporter (5HTt): physiological influences on kinetic characteristics in a large human population. Platelets. 2010;21(6):429-38. CrossRef PubMed
  28. Richter T, Paluch Z, Alusik S. The non-antidepressant effects of citalopram: a clinician's perspective. Neuro Endocrinol Lett. 2014;35(1):7-12.
  29. Bradaschia-Correa V, Josephson AM, Mehta D, Mizrahi M, Neibart SS, Liu C, Kennedy O, Castillo AB, Egol KA, Leucht P. Fluoxetine inhibits osteoblast differentiation and mineralization in fracture healing. J Bone Miner Res. 2017 Apr;32(4): 821-33. CrossRef PubMed PubMedCentral
  30. Bertaccini G. Tissue 5-hydroxytryptamine and urinary 5-hydroxyindoleacetic acid after partial or total removal of the gastro-intestinal tract in the rat. J Physiol. 1960;153(2):239-49. CrossRef PubMed PubMedCentral
  31. Stunes AK, Reseland JE, Hauso O, Kidd M, Tommeras K, Waldum HL. Adipocytes express a functional system for serotonin synthesis, reuptake and receptor activation. Diabetes Obes Metab. 2011;13(6):551-8. CrossRef PubMed
© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2024.